Conference Reports for NATAP
EASL 45th Annual Meeting
April 14-18, 2010
Antiviral Activity, Pharmacokinetics & Safety of IDX184 in Combination with Peg/Rbv in Treatment Na´ve Genotype 1
Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
J Lalezari F Poordad, E Dejesus, E Godofky, D Mayers et al.